It has been announced by the British government that the use of cannabis for medical use will be reviewed.

As the current setup is proving inadequate to answer the concerns of the healthcare sector, U.K. Home Secretary Sajid David informed the country’s Parliament that there is a need to examine the use of cannabis-based medicines in health services.

The issue gained widespread public attention following the application by a boy’s family suffering from a rare form of epilepsy to use cannabis oil medication. The Home Secretary stated that a license would be issued for the boy’s treatment procedure to go ahead.

The pressure on the British government was augmented after cannabis brought from Canada was confiscated by Heathrow Airport officials for treatment of the 12-year-old boy suffering from serious seizures. The U.K. has banned Cannabis oil with more than 0.05 percent of the psychoactive element THC (tetrahydrocannabinol)

It has also been found that Cannabis oil diminish symptoms of multiple sclerosis (MS) and the U.K. has licensed the use of one drug, Savitex, for helping patients suffering from MS, but only when other drugs fail.

It was made clear to lawmakers by the Home Secretary that the government was harboring no plans to fully legalize the use of cannabis for recreational purposes.